Statistics

Total Visits

Views
The impact of EGFR T790M mutations and BIM mRNA expression on outcome in patients with EGFR-mutant NSCLC treated with erlotinib or chemotherapy in the randomized phase III EURTAC trial44

Select a period of time:

Number of views in the range

Views
The impact of EGFR T790M mutations and BIM mRNA expression on outcome in patients with EGFR-mutant NSCLC treated with erlotinib or chemotherapy in the randomized phase III EURTAC trial28

Views

Views
March 202516
April 20253
May 20251
June 20251
July 20257
August 20250
September 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore18
Brazil5
Spain2
United Kingdom1
Mexico1
United States1
 

Top cities views

Views
Belo Horizonte1
Council Bluffs1
Criciúma1
Itaboraí1
Lugo1
Luis Eduardo Magalhães1
Nova Iguaçu1
Querétaro City1